Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SlovakiaBack to Slovakia

Clinical trials in Poprad – page 3

32 clinical trials in Poprad, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Poprad at a glance
32
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

32 trials in Poprad

Open in trial search

Urinary tract infection

Not recruiting

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

Registered drug
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Colorectal cancer

Not recruiting

Study for Patients with Metastatic Colorectal Cancer with BRAF V600E Mutation Using Encorafenib, Cetuximab, and Chemotherapy Combination

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Pfizer Inc.

Non-small cell lung cancer+2

Not recruiting

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Gastrointestinal melanoma+7

Not recruiting

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Binimetinib
  • Sponsor:Pfizer Inc.

Gastrointestinal melanoma+7

Not recruiting

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Binimetinib
  • Sponsor:Pfizer Inc.

Colorectal cancer metastatic+4

Not recruiting

Study on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:Pfizer Inc.

Asthma

Not recruiting

Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Poprad

What the registry says about research in the country

01 Respiratory Medicine

Innovative research focusing on non-small cell lung cancer treatments and advanced asthma management. Studies evaluate novel combination therapies and long-term disease control approaches.

  • Advanced NSCLC Treatments
  • Severe Asthma Management
  • Targeted Lung Therapies

Multiple trials investigating breakthrough treatments for patients with specific genetic markers and varying disease stages.

02 Rheumatology

Comprehensive studies examining new treatments for psoriatic arthritis, with particular focus on biologic therapies and disease-modifying treatments.

  • Axial Disease Management
  • Novel Biologic Therapies
  • DMARD-Resistant Cases

Research aims to improve symptom control and quality of life for patients with various forms of arthritis.

03 Oncology

Groundbreaking research in advanced melanoma and colorectal cancer, exploring targeted therapies and combination treatments for specific genetic mutations.

  • Metastatic Melanoma
  • Colorectal Cancer
  • Targeted Therapies

Studies focus on personalized treatment approaches based on genetic markers and disease characteristics.

04 Metabolic Disorders

Research addressing familial hypercholesterolemia and type 2 diabetes, investigating innovative treatment approaches and long-term disease management strategies.

  • Cholesterol Management
  • Diabetes Control
  • Metabolic Optimization

Trials aim to improve treatment outcomes and patient care in chronic metabolic conditions.

Back to SlovakiaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.